Medtronic Secures FDA Approval for OmniaSecure Lead
Galway, Ireland | March 23, 2026 Medtronic plc has announced that the U.S. Food and Drug Administration (FDA) has...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Galway, Ireland | March 23, 2026 Medtronic plc has announced that the U.S. Food and Drug Administration (FDA) has...
RAHWAY, N.J. — December 3, 2025 — Mexico’s Secretariat of Agriculture and Rural Development (SADER) has granted approval for...
Minneapolis, MN — December 3, 2025 — Medtronic announced that the U.S. Food and Drug Administration (FDA) has granted...
ANTWERP, Belgium – November 12, 2025 — Minze Health, a digital health company focused on urinary and bladder conditions,...
